Skip to main content

Advertisement

Log in

Addressing Within-Role Conflicts of Interest in Surgery

  • Original Research
  • Published:
Journal of Bioethical Inquiry Aims and scope Submit manuscript

Abstract

In this paper we argue that surgeons face a particular kind of within-role conflict of interests, related to innovation. Within-role conflicts occur when the conflicting interests are both legitimate goals of professional activity. Innovation is an integral part of surgical practice but can create within-role conflicts of interest when innovation compromises patient care in various ways, such as by extending indications for innovative procedures or by failures of informed consent. The standard remedies for conflicts of interest are transparency and recusal, which are unlikely to address this conflict, in part because of unconscious bias. Alternative systemic measures may be more effective, but these require changes in the culture of surgery and accurate identification of surgical innovation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. If surgical techniques could be patented, then they too would invoke more traditional financial conflicts of interest. It is also possible that surgeons or hospitals advertising particular innovative procedures may attract patients on this basis, thereby creating potential financial conflicts of interest.

  2. This dual role may lead to financial conflicts of interest—for example, through over-servicing—but this is not our concern here.

  3. There are other areas of non-surgical health care practice where similar issues arise; for instance, interventional radiology or cardiology, psychology, or dentistry.

  4. Of course, surgeons are not alone in taking up new procedures without good evidence. For instance, bone marrow transplantation was used to treat breast cancer for more than 10 years in spite of inadequate evidence regarding its effectiveness (Welch and Mogielnicki 2002).

  5. For example, 40 years ago it became popular to perform an anastomosis between the common bile duct and duodenum at the time of removing the gall bladder on the basis that any gallstones remaining in the biliary tree could thereby easily enter the gastrointestinal tract. This procedure did not involve any external commercial interests such as device manufacturing companies. Surgeons were, however, keen to perform the operation to showcase this new technique. Unfortunately, the outcomes for patients were poor due to long-term complications from biliary tract infection.

  6. We note that where innovation occurs in relation to unexpected anatomical anomalies or intra-operative events, it is not possible to halt the operation and awaken the patient to explain the new situation. In these cases, emergency innovation falls within the discretionary scope of clinical practice.

References

  • Barkun, J.S., J.K. Aronson, L.S. Feldman, et al. 2009. Surgical innovation and evaluation 1: Evaluation and stages of surgical innovations. The Lancet 374(9695): 1089–1096.

    Article  Google Scholar 

  • Bell, E., G. Mathieu, and E. Racine. 2009. Preparing the ethical future of deep brain stimulation. Surgical Neurology 72(6): 577–586.

    Article  PubMed  Google Scholar 

  • Biffl, W.L., D.A. Spain, A.M. Reitsma, et al. 2008. Responsible development and application of surgical innovations: A position statement of the society of university surgeons. Journal of the American College of Surgeons 206(3): 1204–1209.

    Article  PubMed  Google Scholar 

  • Brody, H., and F.G. Miller. 2003. The clinician–investigator: Unavoidable but manageable tension. Kennedy Institute of Ethics Journal 13(40): 329–346.

    Article  PubMed  Google Scholar 

  • Dana, J. 2009. How psychological research can inform policies for dealing with conflicts of interest in medicine. In Conflict of interest in medical research, education, and practice, ed. B. Lo and M.J. Field, 358–374. Washington, DC: The National Academies Press.

    Google Scholar 

  • Emanuel, E.J., and D.F. Thompson. 2008. The concept of conflicts of interest. In The Oxford textbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, et al., 758–766. New York: Oxford University Press.

    Google Scholar 

  • Ergina, P.L., J.A. Cook, J.M. Blazeby, et al. 2009. Surgical innovation and evaluation 2: Challenges in evaluating surgical innovation. The Lancet 374(9695): 1097–1104.

    Article  Google Scholar 

  • Frader, J.E., and D.A. Caniano. 1998. Research and innovation in surgery. In Surgical ethics, ed. L.B. McCullogh, J.W. Jones, and B.A. Brody, 217–241. New York: Oxford University Press.

    Google Scholar 

  • Kessels, R.P. 2003. Patients’ memory for medical information. Journal of the Royal Society of Medicine 96(5): 219–222.

    Article  PubMed  Google Scholar 

  • Lemmens, T. 2008. Conflict of interest in medical research: Historical development. In The Oxford textbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, et al., 747–757. New York: Oxford University Press.

    Google Scholar 

  • Lo, B., and M.J. Field (eds.). 2009. Conflict of interest in medical research, education, and practice. Washington, DC: The National Academies Press.

    Google Scholar 

  • Loewenstein, G., S. Sah, and D.M. Cain. 2012. The unintended consequences of conflict of interest disclosure. The Journal of the American Medical Association 307(7): 669–670.

    Article  Google Scholar 

  • Mastroianni, A.C. 2006. Liability, regulation and policy in surgical innovation: The cutting edge of research and therapy. Health Matrix: Journal of Law and Medicine 16(2): 351–442.

    Google Scholar 

  • McCulloch, P., D.G. Altman, W.B. Campbell, et al. 2009. Surgical innovation and evaluation 3: No surgical innovation without evaluation: The IDEAL recommendations. The Lancet 374(9695): 1105–1112.

    Article  Google Scholar 

  • Miller, F. 2005. Ethical issues in surgical research. Thoracic Surgery Clinics. 15(4): 543–554.

    Article  PubMed  Google Scholar 

  • Morgan, M.A., J. Dana, G. Loewenstein, S. Zinberg, and J. Schulkin. 2006. Interactions of doctors with the pharmaceutical industry. Journal of Medical Ethics 32(10): 559–563.

    Article  PubMed  CAS  Google Scholar 

  • NSW Health. 2003. Model policy for the safe introduction of new interventional procedures. www.health.nsw.gov.au/policies/PD/2005/pdf/PD2005_333.pdf. Accessed September 28, 2012.

  • Ramsay, C.R., A.M. Grant, S.A. Wallace, P.H. Garthwaite, A.F. Monk, and I.T. Russell. 2001. Statistical assessment of the learning curves of new technologies: A systematic review. Health Technology Assessment 5(12): 1–79.

    PubMed  CAS  Google Scholar 

  • Reitsma, A.M., and J.D. Moreno. 2006. Ethics of innovative surgery: U.S. surgeons’ definitions, knowledge, and attitudes. In Ethical guidelines for innovative surgery, ed. A.M. Reitsma and J.D. Moreno, 173–198. Hagerstown, MD: University Publishing Group.

    Google Scholar 

  • Royal Australasian College of Surgeons/ASERNIP-S. 2008. General guidelines for assessing, approving and introducing new surgical procedures into a hospital or health service, 2nd ed. Stepney, South Australia: Royal Australasian College of Surgeons.

    Google Scholar 

  • Schwarze, M.L. 2009. Conflict of interest with industry and the challenges for surgical education. Journal of the American College of Surgeons 209(6): 766–768.

    Article  PubMed  Google Scholar 

  • Thompson, D. 1993. Understanding financial conflicts of interest. The New England Journal of Medicine 329(8): 573–576.

    Article  PubMed  CAS  Google Scholar 

  • Welch, H.G., and J. Mogielnicki. 2002. Presumed benefit: Lessons from the American experience with marrow transplantation for breast cancer. British Medical Journal 324(7345): 1088–1092.

    Article  PubMed  Google Scholar 

  • Zevin, B., R. Aggarwal, and T.P. Grantcharov. 2012. Simulation-based training and learning curves in laparoscopic Roux-en-Y gastric bypass. British Journal of Surgery 99(7): 887–895.

    Article  PubMed  CAS  Google Scholar 

  • Zipkin, D., and M. Steinman. 2005. Interactions between pharmaceutical representatives and doctors in training: A thematic review. Journal of General Internal Medicine 20(8): 777–786.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the audience at the annual conference of the Australasian Association of Bioethics and Health Law in July 2011 for helpful comments; we also thank members of the INCISIVE working group on conflicts of interest for feedback and comments.

Disclosure of Competing Interests

The authors have no financial or professional relationships that may pose a competing interest in relation to the content of this paper.

Funding

Research towards this paper was partly supported by an Australian Research Council (ARC) Linkage Grant (LP110200217), “On the Cutting Edge: Promoting Best Practice in Surgical Innovation.” The ARC had no control or influence over the decision to submit the final version of the manuscript for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wendy A. Rogers.

Additional information

A version of this paper was presented at the annual conference of the Australasian Association of Bioethics and Health Law in July 2011. Research toward this paper was partly supported by an Australian Research Council grant (LP110200217).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogers, W.A., Johnson, J. Addressing Within-Role Conflicts of Interest in Surgery. Bioethical Inquiry 10, 219–225 (2013). https://doi.org/10.1007/s11673-013-9431-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11673-013-9431-1

Keywords

Navigation